Diagnostic Center | March 23, 2024
AstraZeneca’s FLAURA2 Phase III trial showed favourable trend in EGFR-mutated advanced lung cancer
Combination shows consistent benefit across prespecified post-progression outcomes
Combination shows consistent benefit across prespecified post-progression outcomes
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
The pilot plant is focused on scaling up beverage production and will support applications
A five-day inspection was concluded successfully with no critical and no major observations raised
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
Women emerge as the cornerstone of this monumental undertaking
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
Subscribe To Our Newsletter & Stay Updated
